Evotec (OTCMKTS:EVTCY) Reaches New 52-Week Low at $4.48

Evotec SE (OTCMKTS:EVTCYGet Free Report)’s stock price hit a new 52-week low during mid-day trading on Thursday . The stock traded as low as $4.48 and last traded at $4.56, with a volume of 73687 shares trading hands. The stock had previously closed at $4.83.

Evotec Stock Down 0.2 %

The company has a debt-to-equity ratio of 0.53, a current ratio of 2.57 and a quick ratio of 2.50. The firm has a market capitalization of $1.50 billion, a P/E ratio of 11.10 and a beta of 0.98. The business has a 50 day moving average price of $5.65 and a 200 day moving average price of $7.61.

About Evotec

(Get Free Report)

Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.

Further Reading

Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.